The chemo drug will be cheaper because it's basically ready for clinicals and they think they can fast track it. The glaucoma drug will be relatively cheap compared to other drugs because it's easier to test and the results aren't subjective like if they were doing a drug for pain. They still have to make the drug and I think they're nailing down a delivery system. Probably ready by the end of the year.
News 
Market Data 
Discover 
